Searched for
TRASTUZUMAB REZETECAN
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- Glenmark Pharma shares in focus on $1.1 billion deal for oncology drugGlenmark Pharma shares: The company's unit Glenmark Specialty S.A. signed an exclusive licensing deal with China’s Hengrui Pharma for Trast...
- Stocks in news: Glenmark Pharma, Adani Energy, Dr Reddy's, Tata Motors, Newgen SoftwareMarkets declined due to global and domestic pressures, with the Nifty testing support at 25040. Glenmark Pharma partnered with Hengrui Phar...
- Glenmark inks pact with Hengrui Pharma for cancer therapy Trastuzumab RezetecanGlenmark Pharmaceuticals has partnered with Hengrui Pharma, securing exclusive rights to develop and commercialize Trastuzumab Rezetecan gl...
Load More